NEW CASTLE, Del., Sept. 20, 2012 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's RapiMed pain reliever for children was the focus of a feature article in the September 17th edition of "The News Journal" based in Wilmington, DE, also known as Delawareonline.com.
The article, titled "Easing Away Pain," published in The News Journal's innovation section, focuses on ScripsAmerica's new RapiMed children's' pain reliever, highlighting how the Company believes the product will receive a strong consumer response and could potentially have a significant impact on revenue next year. RapiMed eliminates the need for parents to use measuring cups, spoons, syringes or water to provide their children with a pain reliever.
ScripsAmerica believes that RapiMed, which is scheduled for release within the next six months, will have a competitive advantage over Tylenol's "Meltaways" product because it melts much faster, is much smaller and contains no sugar. Upon its launch, ScripsAmerica will distribute RapiMed through big box superstores and pharmacies as well as implement a regional marketing campaign that will include savings coupons.
"The News Journal" is owned by Gannett Company, Inc., a publicly traded media holding company and the largest U.S. newspaper publisher, as measured by total daily circulation. Headquartered in Tysons Corner, Virginia, Gannett's assets include the national newspaper "USA Today" and the "USA Weekend."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies through the largest pharmaceutical distributor in North America, McKesson Corporation. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, Curtis Pharmaceuticals, MedVet and the United States Veterans Administration.
For more information please visit: www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.